Avastin, a drug used to fight certain types of cancers, has been pulled by the U.S. Food and Drug Administration from the market as a treatment of breast cancer. The FDA concluded that Avastin has not been shown to be effective and safe for treating breast cancer. However, the drug will stay on the market as an approved treatment for certain types of brain, lung, kidney and colon cancer.
Risks of Avastin include:
- severe high blood pressure
- hemorrhaging and bleeding
- heart attack or heart failure
- the development of perforations in different part of the body including nose, intestines and stomach.
The prescription medicine is manufactured by Genentech. Used for metastatic breast cancer, Avastin has not been shown to provide a benefit – in terms of delay in tumor growth – that would justify its serious and potentially life-threatening risks. Additionally, the FDA says there is no evidence that Avastin will either improve the quality of life for women with breast cancer or help them live longer.
If you have been prescribed Avastin for metastatic breast cancer and have had serious medical problems which you believe have been caused by taking Avastin, you should contact a pharmaceutical lawyer at Carr & Carr Attorneys. With offices in Tulsa, Oklahoma City and Northwest Arkansas in Springdale, we can discuss your situation with you and help you decide on a course of action.
No related posts.